HONG KONG, Oct 17, 2022 – (ACN Newswire) – EC Healthcare (the “Company”, which along with its subsidiaries is in most cases known as the “Group”, SEHK stock code: 2138), the final observe non-neatly being middle clinical crew in Hong Kong*, is pleased to yelp that the Group expects to end a document-high semi-annual gross sales quantity from April to September 2022 (the “Reporting Duration”).The inquire of on clinical companies and products offered by the Group stays solid and the Group’s alternate prove resilience and momentum backed by the Group’s diverse alternate. The Board expects the Group to end a document-high semi-annual total gross sales quantity of as a minimal HK$1.8 billion for the Reporting Duration, representing a as a minimal 17% y-o-y lengthen. The Group expects to end a as a minimal 30% y-o-y lengthen for clinical companies and products gross sales quantity. Sales quantity of loads of companies and products rose by as a minimal 95% y-o-y, primarily driven by the acquisition of veterinary corporations.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, EC Healthcare is constantly dedicated to constructing a various healthcare ecosystem to maximise clients’ lifetime price. Hong Kong resident now step by step constructing a herd immunity barrier with a population the cumulative number of reported cases of 5th wave of COVID-19 has reached over 181 million, population accomplished the third vaccine dose became once at roughly 80.2% as of 13 October 2022. The actual recovery in local user sentiment is anticipated to revenue the Group’s alternate. Searching ahead, the Group is optimistic about its alternate sort as the Hong Kong authorities’s pandemic policy stance is heading in opposition to “Normalization” and recently additional relaxed quarantine arrangements for inbound vacationers, additional boosting the market sentiment. The Group will continue to obtain larger its corporations thru organic development as well to mergers and acquisitions, leveraging funding in IT, sign and restore to complement the Group’s enclosed diverse ecosystem. The Group will additional enhance the resilience and capacity to withstand economic cyclical adjustments and additional consolidate the healthcare market.”
About EC Healthcare
EC Healthcare is Hong Kong’s biggest non-neatly being middle clinical carrier provider*, leveraging its core corporations of preventive and precision medication, and dedicated to developing clinical synthetic intelligence by integrating its multi-disciplinary clinical companies and products. The toddle, which is supported by the Group’s high-end branding and quality customer companies and products, is aimed at offering clients stable and efficient healthcare and clinical companies and products with professionalism. The Group is a constituent stock of the Hold Seng Composite Index and the MSCI Hong Kong Limited Cap Index.
The Group mostly engages within the provide of 1-discontinue clinical and neatly being care companies and products in Higher China. The Group affords a full differ of companies and products and merchandise below its neatly-identified manufacturers, including those of its one-discontinue lovely clinical solutions provider DR REBORN which has ranked first in Hong Kong by gross sales for years, a educated hair care middle HAIR FOREST, important care clinics collectively established with neatly being management centre re:HEALTH, a vaccine centre Hong Kong Expert Vaccine HKPV, Overall outpatient health center Tencent Doctorwork, the final observe one-discontinue disaster management centre in Hong Kong New York Clinical Group, the excellent dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Successfully being and Care Dental Clinic, a sophisticated diagnostic and imaging centre HKAI, an oncology therapy centre reVIVE, a day procedure centre HKMED, a arena of skills health center PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Clinical Laboratories, Ophthalmology Heart VIVID EYE and EC Veterinary Clinic and Imaging Heart.
*In step with self sustaining be taught performed by Frost and Sullivan by device of revenue in 2020 and 2021
For additional files, please contact:
iPR Ogilvy Restricted
Callis Lau / Lorraine Luk / Tim Tin / Sophia Wu
Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 / 3920 7645
Fax: (852) 3170 6606
Electronic mail: [email protected]
Topic: Press liberate summary
Provide: EC Healthcare
Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Company Recordsdata Network
Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Company Recordsdata Network.
